Description

LOVEGRA ORAL JELLY (1×7)

Indications

LOVEGRA Oral Jelly is primarily indicated for the treatment of erectile dysfunction (ED) in men. Erectile dysfunction is a condition characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. LOVEGRA is designed to enhance sexual arousal and improve erectile function, thereby facilitating a more fulfilling sexual experience.

Mechanism of Action

LOVEGRA Oral Jelly contains the active ingredient sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor. The mechanism of action involves the inhibition of the PDE5 enzyme, which leads to an increase in the levels of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. This increase in cGMP results in the relaxation of smooth muscle and vasodilation, allowing for increased blood flow to the penis upon sexual stimulation. Consequently, this enhances the ability to achieve and maintain an erection.

Pharmacological Properties

Sildenafil citrate, the active component of LOVEGRA, is rapidly absorbed after oral administration, with peak plasma concentrations typically reached within 30 to 120 minutes. The bioavailability of sildenafil is approximately 40%, and its effects can last for up to four to six hours. The drug is metabolized primarily in the liver by cytochrome P450 enzymes, particularly CYP3A4, and is excreted mainly in the feces and urine. It is important to note that the presence of food, especially high-fat meals, can delay the onset of action of LOVEGRA.

Contraindications

LOVEGRA Oral Jelly is contraindicated in patients who are hypersensitive to sildenafil or any of the excipients in the formulation. It should not be used in conjunction with nitrates in any form, as this combination can lead to severe hypotension. Additionally, patients with severe cardiovascular disorders, such as unstable angina or recent history of myocardial infarction, should avoid using this medication. LOVEGRA is also contraindicated in individuals who are advised against sexual activity due to underlying health conditions.

Side Effects

Common side effects associated with LOVEGRA Oral Jelly include headache, flushing, dyspepsia, nasal congestion, and dizziness. These side effects are generally mild to moderate in intensity and tend to resolve on their own. However, serious adverse effects, although rare, may occur. These include priapism (a prolonged and painful erection), sudden hearing loss, and vision changes, including loss of vision. Patients experiencing any severe side effects should seek immediate medical attention.

Dosage and Administration

The recommended starting dose of LOVEGRA Oral Jelly is 50 mg, taken approximately one hour before sexual activity. Depending on efficacy and tolerability, the dose may be adjusted to a maximum of 100 mg or reduced to 25 mg. LOVEGRA should not be taken more than once daily. The jelly form allows for easy administration and may be taken with or without food, although it is advisable to avoid high-fat meals to ensure optimal absorption and effectiveness.

Interactions

LOVEGRA may interact with various medications, which can affect its efficacy and safety. Notably, concomitant use with nitrates can lead to significant hypotension. Other medications that may interact with LOVEGRA include alpha-blockers, antihypertensives, and certain antifungal agents such as ketoconazole. It is essential for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before using LOVEGRA Oral Jelly, patients should undergo a thorough medical evaluation to identify any underlying health conditions that may contraindicate its use. Caution is advised in patients with a history of cardiovascular disease, renal impairment, or liver dysfunction, as these conditions may affect the metabolism and clearance of sildenafil. Additionally, patients should be informed about the potential risks of sexual activity, especially if they have pre-existing cardiovascular issues.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction. In a randomized, double-blind, placebo-controlled trial involving men with ED, sildenafil demonstrated a significant improvement in the ability to achieve and maintain an erection compared to placebo. The study results indicated that sildenafil was effective across various age groups and etiologies of erectile dysfunction. Adverse effects were generally mild and transient, supporting the favorable safety profile of LOVEGRA.

Conclusion

LOVEGRA Oral Jelly is an effective treatment option for men suffering from erectile dysfunction. Its convenient jelly formulation and rapid onset of action make it a practical choice for enhancing sexual performance. As with any medication, it is crucial for patients to use LOVEGRA responsibly and under the guidance of a healthcare provider to ensure safety and efficacy.